Terms: = Leukemia AND REL, I-Rel, 5966, ENSG00000162924, C-Rel AND Clinical Outcome
2 results:
1. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia.
Ramos-Muntada M; Trincado JL; Blanco J; Bueno C; Rodríguez-Cortez VC; Bataller A; López-Millán B; Schwab C; Ortega M; Velasco P; Blanco ML; Nomdedeu J; Ramírez-Orellana M; Minguela A; Fuster JL; Cuatrecasas E; Camós M; Ballerini P; Escherich G; Boer J; DenBoer M; Hernández-Rivas JM; Calasanz MJ; Cazzaniga G; Harrison CJ; Menéndez P; Molina O
Mol Oncol; 2022 Aug; 16(16):2899-2919. PubMed ID: 35726693
[TBL] [Abstract] [Full Text] [Related]
2. rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia.
Hewamana S; Lin TT; Rowntree C; Karunanithi K; Pratt G; Hills R; Fegan C; Brennan P; Pepper C
J Clin Oncol; 2009 Feb; 27(5):763-9. PubMed ID: 19124804
[TBL] [Abstract] [Full Text] [Related]
